PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Unit of Endocrinology & Diabetes, Campus Bio-Medico University of Rome, Italy.\', \'Department of Experimental Medicine, Sapienza University of Rome, Italy.\', \'Department of Internal Medicine, Section of Endocrinology and Diabetes, South-Tyrolean Healthcare System, Bolzano General Hospital, Bolzano, Italy.\', \'Department of Medicine, Unit of Geriatrics, Campus Bio-Medico University of Rome, Italy.\', \'Department of Medicine, Unit of Endocrinology & Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: p.pozzilli@unicampus.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0168-8227(20)30697-510.1016/j.diabres.2020.108444
?:doi
?:hasPublicationType
?:journal
  • Diabetes research and clinical practice
is ?:pmid of
?:pmid
?:pmid
  • 32946854
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.538
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all